Dmytro Kornyeyev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Dmytro Kornyeyev has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Eugene W. Krueger
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA
1 shared publication - Hong Cao
Center for Basic Research in Digestive Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
1 shared publication - Huiling Yang
Gilead Sciences, Inc., Foster City, California, USA
1 shared publication - Jane Tam
Gilead Sciences, Inc., Foster City, California, USA
1 shared publication - Jia Jun Chia
Gilead Sciences, Inc., Foster City, California, USA
1 shared publication - Jing Chen
Center for Basic Research in Digestive Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
1 shared publication
Latest Publications
- Open Access
- 22 May 2026
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 10 (6)
Secretion of the HBV small surface antigen is driven by an ER autophagic pathway
Chronic hepatitis B (CHB), a major global public health burden, is characterized by the presence of high circulating levels of non-infectious subviral particles (SVPs). These SVPs are mainly composed of small hepatitis B surface antigen (SHBs) and are associated with a dysfunctional HBV-specific immune response. Previous studies exploring the cellular mechanisms and molecular pathways by which SVPs are secreted from hepatocytes have utilized either non-hepatic cells or whole-genome HBV-integrated hepatoma cell lines in which SHBs can also be secreted as a component of the virion envelope. In this study, we provide a detailed examination of SHBs trafficking using biochemical approaches coupled with high-resolution confocal microscopy and live-cell imaging via a novel fluorophore-tagged SHBs probe in both HepG2 and primary human hepatocytes stably expressing SHBs. Our results provide evidence that SHBs utilize a modified ER-Golgi secretory pathway with transit from the ER to the multivesicular body and lysosomal/late endosomal compartments. Importantly, we identified the autophagy adapters ATG5 and LC3B, and the ER-phagy protein atlastin 3 (ATL3), central to mediating SHBs secretion. These findings suggest that SHBs is trafficked through a non-canonical path for secretion and provides new potential therapeutic targets for the treatment of CHB.
- 22 May 2026
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 10 (6)
Open AccessSecretion of the HBV small surface antigen is driven by an ER autophagic pathway
Chronic hepatitis B (CHB), a major global public health burden, is characterized by the presence of high circulating levels of non-infectious subviral particles (SVPs). These SVPs are mainly composed of small hepatitis B surface antigen (SHBs) and are associated with a dysfunctional HBV-specific immune response. Previous studies exploring the cellular mechanisms and molecular pathways by which SVPs are secreted from hepatocytes have utilized either non-hepatic cells or whole-genome HBV-integrated hepatoma cell lines in which SHBs can also be secreted as a component of the virion envelope. In this study, we provide a detailed examination of SHBs trafficking using biochemical approaches coupled with high-resolution confocal microscopy and live-cell imaging via a novel fluorophore-tagged SHBs probe in both HepG2 and primary human hepatocytes stably expressing SHBs. Our results provide evidence that SHBs utilize a modified ER-Golgi secretory pathway with transit from the ER to the multivesicular body and lysosomal/late endosomal compartments. Importantly, we identified the autophagy adapters ATG5 and LC3B, and the ER-phagy protein atlastin 3 (ATL3), central to mediating SHBs secretion. These findings suggest that SHBs is trafficked through a non-canonical path for secretion and provides new potential therapeutic targets for the treatment of CHB.
- 1 February 2016
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 310 (3) , H426-H435
Contribution of the late sodium current to intracellular sodium and calcium overload in rabbit ventricular myocytes treated by anemone toxin
Pathological enhancement of late Na+current ( INa) can potentially modify intracellular ion homeostasis and contribute to cardiac dysfunction. We tested the hypothesis that modulation of late INacan be a source of intracellular Na+([Na+]i) overload. Late INawas enhanced by exposing rabbit ventricular myocytes to Anemonia sulcata toxin II (ATX-II) and measured using whole cell patch-clamp technique. [Na+]iwas determined with fluorescent dye Asante NaTRIUM Green-2 AM. Pacing-induced changes in the dye fluorescence measured at 37°C were more pronounced in ATX-II-treated cells than in control (dye washout prevented calibration). At 22–24°C, resting [Na+]iwas 6.6 ± 0.8 mM. Treatment with 5 nM ATX-II increased late INa8.7-fold. [Na+]imeasured after 2 min of electrical stimulation (1 Hz) was 10.8 ± 1.5 mM and 22.1 ± 1.6 mM ( P < 0.001) in the absence and presence of 5 nM ATX-II, respectively. Inhibition of late INawith GS-967 (1 μM) prevented Na+iaccumulation. A strong positive correlation was observed between the late INaand the pacing-induced increase of [Na+]i( R2= 0.88) and between the rise in [Na+]iand the increases in cytosolic Ca2+( R2= 0.96). ATX-II, tetrodotoxin, or GS-967 did not affect [Na+]iin quiescent myocytes suggesting that late INawas solely responsible for triggering the ATX-II effect on [Na+]i. Experiments with pinacidil and E4031 indicate that prolongation of the action potential contributes to as much as 50% of the [Na+]ioverload associated with the increase in late INacaused by ATX-II. Enhancement of late INacan cause intracellular Na+overload in ventricular myocytes.
- 1 February 2016
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 310 (3) , H426-H435
Contribution of the late sodium current to intracellular sodium and calcium overload in rabbit ventricular myocytes treated by anemone toxin
Pathological enhancement of late Na+current ( INa) can potentially modify intracellular ion homeostasis and contribute to cardiac dysfunction. We tested the hypothesis that modulation of late INacan be a source of intracellular Na+([Na+]i) overload. Late INawas enhanced by exposing rabbit ventricular myocytes to Anemonia sulcata toxin II (ATX-II) and measured using whole cell patch-clamp technique. [Na+]iwas determined with fluorescent dye Asante NaTRIUM Green-2 AM. Pacing-induced changes in the dye fluorescence measured at 37°C were more pronounced in ATX-II-treated cells than in control (dye washout prevented calibration). At 22–24°C, resting [Na+]iwas 6.6 ± 0.8 mM. Treatment with 5 nM ATX-II increased late INa8.7-fold. [Na+]imeasured after 2 min of electrical stimulation (1 Hz) was 10.8 ± 1.5 mM and 22.1 ± 1.6 mM ( P < 0.001) in the absence and presence of 5 nM ATX-II, respectively. Inhibition of late INawith GS-967 (1 μM) prevented Na+iaccumulation. A strong positive correlation was observed between the late INaand the pacing-induced increase of [Na+]i( R2= 0.88) and between the rise in [Na+]iand the increases in cytosolic Ca2+( R2= 0.96). ATX-II, tetrodotoxin, or GS-967 did not affect [Na+]iin quiescent myocytes suggesting that late INawas solely responsible for triggering the ATX-II effect on [Na+]i. Experiments with pinacidil and E4031 indicate that prolongation of the action potential contributes to as much as 50% of the [Na+]ioverload associated with the increase in late INacaused by ATX-II. Enhancement of late INacan cause intracellular Na+overload in ventricular myocytes.